Salarius Pharmaceuticals
SLRX
SLRX
11 hedge funds and large institutions have $104K invested in Salarius Pharmaceuticals in 2025 Q2 according to their latest regulatory filings, with 6 funds opening new positions, 2 increasing their positions, 1 reducing their positions, and 1 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
11
Holders Change
+5
Holders Change %
+83.33%
% of All Funds
0.15%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
6
Increased
2
Reduced
1
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
1 |
HF
HRT Financial
New York
|
+$28K |
2 |
CSS
Cubist Systematic Strategies
Stamford,
Connecticut
|
+$15K |
3 |
Goldman Sachs
New York
|
+$14.9K |
4 |
Barclays
London,
United Kingdom
|
+$7K |
5 |
Citigroup
New York
|
+$5.28K |
Top Sellers
1 |
UBS Group
Zurich,
Switzerland
|
-$14K |
2 |
TSS
Two Sigma Securities
New York
|
-$11.6K |
3 |
Morgan Stanley
New York
|
-$5 |
4 |
BlackRock
New York
|
-$1 |
5 |
SS
SBI Securities
Tokyo,
Japan
|
-$1 |